Dandruff and active ingredients used in antidandruff shampoos – a review Review article
Article Sidebar
Main Article Content
Abstract
Dandruff is a chronic disease with a recurrent nature. It is considered part of the spectrum of seborrheic dermatitis. The pathogenesis of dandruff emphasizes the significant role of disruptions in the scalp microbiome (particularly the proliferation of fungi from the Malassezia spp. genus), the influence of androgens, and changes in sebum composition. Dandruff usually presents mildly, and anti-dandruff shampoos are typically a sufficient therapeutic option. Topical ciclopirox olamine is the drug of choice for treating dandruff. Additionally, attention is drawn to avoiding triggers such as overheating or overly aggressive care and using mild care products. In rare cases, when topical treatment does not yield the expected results, systemic treatment may be required.
Article Details
Copyright © by Medical Education. All rights reserved.
References
2. Borda LJ, Wikramanayake TC. Seborrheic Dermatitis and Dandruff: A Comprehensive Review. J Clin Investig Dermatol. 2015; 3: 10.13188/2373-1044.1000019.
3. Xu Z, Zongxiu Wang Z, Yuan C. Dandruff is associated with the conjoined interactions between host and microorganisms. Sci Rep. 2016; 6: 24877.
4. Tao R, Li R, Wang R. Skin microbiome alterations in seborrheic dermatitis and dandruff: A systematic review. Exp Dermatol. 2021; 30: 1546-53.
5. Bolognia JL, Schaffer JV, Cerroni L et al. Dermatologia, wydanie polskie. Medipage, Warszawa 2022.
6. Brzezińska-Wcisło L, Wcisło-Dziadecka D, Lis-Święty A et al. Łupież i łojotokowe zapalenie owłosionej skóry głowy – patogeneza, obraz kliniczny oraz aspekty terapeutyczne. Post Dermatol Alergol. 2007; XXIV(2): 59-64.
7. Baran E, Szepietowski J, Maleszka R et al. Łojotokowe zapalenie skóry i łupież: konsensus postępowania terapeutycznego. Wytyczne rekomendowane przez Polskie Towarzystwo Dermatologiczne. Dermatol Klin. 2006; 8: 229-34.
8. Kaaz K, Matusiak Ł. Postać farmaceutyczna cyklopiroksu a umiejscowienie zmian grzybiczych. Med Fakt. 2017; 2(35).
9. Youn HJ, Kim SY, Park M et al. Efficacy and safety of cream containing climbazole/piroctone olamine for facial seborrheic dermatitis: a single-center, open-label split-face clinical study. Ann Dermatol. 2016; 28: 733-9.
10. Steiner A, Kugarajan K, Wullimann M et al. Margin of safety of pentylene glycol derived using measurements of cutaneous absorption and volatility. Regul Toxicol Pharmacol. 2017; 87: 106-11.